MAPT and hippocampal atrophy: Tau pathology (T) is assessed through CSF phosphorylated tau (p-Tau 181) or tau PET imaging, while neurodegeneration (N) is measured using MRI-detected hippocampal atrophy, fluorodeoxyglucose PET for cerebral glucose metabolism, and CSF total tau levels [57].